Hand-held NMR instrument yields rapid analysis of human tumors

March 28, 2011, National Cancer Institute

Using a handheld molecular imaging device in combination with magnetic nanoparticles and a smartphone, a team of investigators from the Massachusetts General Hospital and Harvard Medical School has developed a fast, portable and potentially inexpensive method of detecting cancer from human biopsy samples. Initial results obtained using fine need biopsies taken from human cancer patients show this device trumps traditional pathological methods, both in terms of speed and diagnostic accuracy.

Ralph Weissleder, co-principal investigator of the MIT-Harvard Center for Cancer Nanotechnology Excellence, led this development project. He and his colleagues published the results of their work in the journal .

Typically, cancer is diagnosed by collecting human tissue samples, either removed surgically or via a fine needle inserted into a lump, and sending the samples to a histopathology laboratory, where over the course of several days the sample is analyzed using various tissue stains that highlight cellular features characteristic of tumors for visualization under a microscope. Such analysis is not only time-consuming, it is semi-quantitative at best and requires the technical expertise of a trained pathologist.

The new approach to cancer diagnosis pioneered by Dr. Weissleder and his collaborators relies on the exquisite sensitivity afforded by (NMR), an analytical technique used routinely by chemists to characterize complex molecules and one that forms the basis of magnetic resonance imaging (MRI). But rather than using a standard, table-sized NMR machine, the Mass General team designed and built a far-less-expensive handheld NMR machine that interfaces with a microfluidic device and sends its results to a smartphone, which is also used to control the device. The device can detect the presence of multiple magnetic nanoparticles, each designed to bind to a specific tumor-associated molecular marker.

In the first round of evaluation, the investigators analyzed fine needle biopsies taken from 50 patients suspected of having malignant abdominal tumors. After a quick preparatory step, the suspension of cells from the biopsy was treated with a mixture of , each designed to bind to one of nine specific cancer biomarkers, and then injected into the device's microfluidic channels. Data signals from the microNMR machine were sent wirelessly to a smartphone for analysis and readout. The instrument correctly identified all 44 samples diagnosed as malignant by standard histopathology.

Based on the data generated in this first set of experiments, the investigators analyzed fine needle biopsies from an additional 20 patients using just four of the tagged nanoparticles. The results from this experiment were even better, demonstrating 96% diagnostic accuracy, far exceeding the 84% accuracy of histopathology, the gold standard of cancer diagnosis. Moreover, the microNMR-smartphone device provides a diagnosis within an hour, compared to three days to obtain results from histopathology.

This work, which is detailed in a paper titled, "Micro-NMR for Rapid Molecular Analysis of Human Tumor Samples," was supported in part by the NCI Alliance for Nanotechnology in Cancer, a comprehensive initiative designed to accelerate the application of nanotechnology to the prevention, diagnosis, and treatment of . An abstract of this paper is available at the journal's website.

Explore further: Smartphone app for cancer diagnosis may be on the way

Related Stories

Implantable Device Offers Continuous Cancer Monitoring

July 21, 2009

(PhysOrg.com) -- Surgical removal of a tissue sample is now the standard for diagnosing cancer. Such procedures, known as biopsies, are accurate but offer only a snapshot of the tumor at a single moment in time.

Measuring Nanoparticle Behavior in the Body Using MRI

December 23, 2008

(PhysOrg.com) -- One of the key steps in the development of any drug or imaging agent intended for human use is measurement of the adsorption, metabolism, and excretion of the drug. Quantifying this collection of pharmacological ...

Mapping Tumor Heterogeneity With Quantum Dots

May 25, 2010

(PhysOrg.com) -- One important discovery made about cancer over the past decade is that as a tumor develops, the molecular identity of its cells begins to diverge. As a result, any given tumor is likely to contain groups ...

Nanoparticles Image Breast Cancer

July 21, 2009

Current methods of detecting breast cancer suffer from low sensitivity, limited spatial resolution, or the need to use complicated and expensive radioisotope-based technologies. A new report from investigators at the Emory-Georgia ...

Recommended for you

Taking steps toward a wearable artificial kidney

October 17, 2018

There just aren't enough kidney transplants available for the millions of people with renal failure. Aside from a transplant, the only alternative for patients is to undergo regular dialysis sessions to clear harmful cellular ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.